Winslow Capital Management, LLC Bio Techne Corp Transaction History

Winslow Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$80.67 - $352.29 $198 Million - $866 Million	2,457,182 Added 355.73%	3,147,924 $261 Million
Q3 2022 Nov 14, 2022	SELL	$282.54 - $391.85 $23.8 Million - $33.1 Million	-84,357 Reduced 10.88%	690,742 $196 Million
Q2 2022 Aug 12, 2022	BUY	$322.67 - $449.65 $13.2 Million - $18.4 Million	40,884 Added 5.57%	775,099 $269 Million
Q1 2022 May 13, 2022	BUY	$353.85 - $487.79 $36.5 Million - $50.3 Million	103,172 Added 16.35%	734,215 $318 Million
Q4 2021 Feb 11, 2022	BUY	$456.15 - $525.06 $154 Million - $177 Million	337,340 Added 114.86%	631,043 $326 Million
Q3 2021 Nov 12, 2021	SELL	$444.87 - $538.88 $528,505 - $640,189	-1,188 Reduced 0.4%	293,703 $142 Million
Q2 2021 Aug 13, 2021	SELL	$387.35 - $450.26 $4.52 Million - $5.25 Million	-11,666 Reduced 3.81%	294,891 $133 Million
Q1 2021 May 13, 2021	BUY	$314.62 - $411.0 $96.4 Million - $126 Million	306,557 New	306,557 $117 Million

601

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.8B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Winslow Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Winslow Capital Management, LLC with notifications on news.